2m 2m 2m 2m 2m 2m 2m
Lifecore Biomed (LFCR)
NASDAQ
$4.43+$0.010 (+0.23%)
Price as of Aug 03, 2026 3:33 PM EDT- $165.8MMarket Cap
- -36.77%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lifecore Biomed (LFCR)
$4.43+$0.010 (+0.23%)
LFCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.42 | ||
Change | +$0.06 (+1.38%) | ||
Open | $4.32 | ||
High | $4.45 | ||
Low | $4.27 | ||
Previous Close | $4.36 | ||
Volume | 78,460 | ||
30-Day Average Volume | 156,136 | ||
1-Week Change | 2.08% | ||
1-Month Change | -15.81% | ||
1-Year Change | -36.77% | ||
3-Year Change | -57.74% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.5M | ||
Total Assets | $225.5M | ||
Market Cap | $165.8M | ||
Enterprise Value | $156.9M | ||
Period: QTR TTM FY | |||
Revenue | $14.2M | ||
Net Income | -$15.0M | ||
Free Cash Flow | N/A | ||
EBIT | -$7.7M | ||
EBITDA | -$5.4M | ||
Net Working Capital | N/A | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | 11 | ||
P/B | -6 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue